Efficacy, quality of life, and safety of methotrexate versus interferon in head-to-head treatment in advanced stages of mycosis fungoides and Sezary syndrome. Prospective trial (NCT02323659)

INTRODUCTION: ESMO guidelines recommend interferon (IFN) and methotrexate (MTX) as first-line systemic therapies in mycosis fungoides (MF) and Sezary syndrome (SS). AIM: A prospective, head-to-head trial comparing the efficacy and safety of INF-α and MTX as first-line treatment in MF/SS patients. MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Chmielowska, Ewa, Sokołowska-Wojdyło, Małgorzata, Olszewska, Berenika, Studziński, Maciej, Grzanka-Gadzińska, Aleksandra, Zabłotna, Monika, Olek-Hrab, Karolina, Iwanowski, Tomasz, Olejniczak, Monika, Krause, Anna, Giebel, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880780/
https://www.ncbi.nlm.nih.gov/pubmed/36751548
http://dx.doi.org/10.5114/ada.2021.106206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880780/
https://www.ncbi.nlm.nih.gov/pubmed/36751548
http://dx.doi.org/10.5114/ada.2021.106206

Ejemplares similares